Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ ATXN3L Polyclonal Antibody

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA555649

Catalog No. PIPA555649


Only null left
Add to Cart

Description

Description

Immunogen sequence: LELSRQETNR EDEHLRSTIE LSMQGSSGNT SQDLPKTSCV TPASEQPKKI KEDYFEKHQQ EQKQQQQQSD LPGHSSYLHE RPTTSSRAIE SDLSDDISEG TVQAAVDTI Highest antigen sequence identity to the following orthologs: Mouse - 46%, Rat - 44%.

ATXN3L also named as ataxin 3 like or MJDL is a 355 amino acid protein, which contains one Josephin domain and two UIM repeats. ATXN3L localizes in nucleus and may cleave poly ubiquitin chain.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

ATXN3L
Polyclonal
Unconjugated
ATXN3L
ataxin 3 like; ataxin 3-like; Ataxin-3-like protein; ATX3L; ATXN3L; Machado-Joseph disease protein 1-like; MJDL; putative ataxin-3-like protein
Rabbit
Antigen affinity chromatography
RUO
92552
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Liquid
Immunohistochemistry (Paraffin)
0.3 mg/mL
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2
Q9H3M9
ATXN3L
Recombinant protein corresponding to Human ATXN3L. Recombinant protein control fragment (Product #RP-92000).
100 μL
Primary
Human
Antibody
IgG
Product Suggestions

Product Suggestions

Videos
Safety and Handling

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.